The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Biffbaffboff - no, you haven't missed the results.
A line from March RNS:
"We are expecting to announce our audited Full Year Results in May 2024"
So maybe some news due with results? Or have I missed those.
My understanding is that firstly we should expect to see a time table which would include recruitment of trial participants. They would receive the dosage for a period, the results analysed, then if looking good approved by the FDA.
This whole process is unlikely to b complete in less than 2 years.
So what we need is some indication that it has really started!
Thanks Canis. I had failed to realize the P140 study only started as recently as Dec last. I would not have expected any update for six months so we should expect one soon, probably with the results. If the study update is decent, the raise will be a lot easier (or IMM might choose to sell some Incanthera to keep the lights on).
From 19th Dec 2023
“As the study continues to move forward in 2024, further details on the study’s timings, protocol and key elements of the clinical trial design will be communicated at regular intervals.”
I can only assume no progress is being made. Have they not even recruited patients to take part - at least that would be something! Nothing on the study since 19th Dec ‘23.
We are all being strung along!! I am thinking there is no real substance to this company.
Next RNS will probably be full year results which will only show cash burn, the need for another raise and therefore dilution.
Anyone any idea when Finals are to be declared? May 11th last year.
"Lanstead has 70m warrants"
It would not suprise me to see Landstead sell their warrant holding (once eventually exercised ) off market to a willing buyer, at a profit to Landstead and with value to a buyer/investor
Repriced last year I should say
Fair point, Nolupus
Lanstead has 70m warrants, Alora Pharma has 22m and Institutional investors c10m reprised last year at 2p .
If warrants are all exercised that will generate c£2m in funding but increase Lanstead's overhang.
So we need some positive newsflow to engineer a breakout.
Only news will change the direction of this share otherwise it will just bounce around the low 2,s
What are your thoughts on timeframe NOLUPUS.
Landstead have a lot of warrants that they Can exercice at 2p so it's logical for them to sell and make a few quid , don't you think ?
More suspected Lanstead selling today of c1m shares
The lack of newsflow is worrying.
I will drop a line to Lisa to express our frustration.
Yorkshirehussar - you know my thoughts on Tek only too well already.
Whilst its share price may continue to recover from the recent lows, adding is too much of a gamble until the company demonstrates it can crystallise profits from any of its holdings.
Much of the recent momentum has come from Microsalt’s rise. But Tek’s locked in there for several months still. A lot can happen (both good & bad) in the interim.
So Tek remains uninvestable for me, though I will retain my current holding in the hope (but not the conviction), I might claw back some of my losses there longer term.
I’m far more hopeful with IMM than Tek to be honest, but both remain a higher than average gamble.
...indicates that there are real signs we are into a positive phase.
Lanstead may have dumped a million shares yesterday but they were all brought back by investors. Good news here would send this up very very quickly. Fingers crossed. TEK seem to be turning a corner as well. Thoughts lordloadsoflolly ?
Now wait for Lanstead to offload toward the close.
Hopefully Lanstead will be gone soon and Immupharma never has to resort to this type of horror funding again.
+10%
Very close now to that 2.5p potential inflection point of interest....
Auction time, something or nothing?
Oooh what did I miss....++++
IMM dared to go blue just now, lasted about a minute. Wonder many shares the selling broker has been given to shift? Silly really because if they waited they would get more and find selling easier...
Yorkshirehussar - I'm perfectly chilled thanks. Just stating facts
Ready for our early doors seller.....then we see what buyers can do and it goes on. Very positive update from INC was great to see fwiw.
New uncle. I see now where you got the 100m projection from. It is just there projected forecast of sales which is great if it comes to fruition. Lordloadsofmisery have a chill. I bet you couldn't enjoy yourself in Disney land.
INC presentation looks very good. Can only add value to IMM. https://www.incanthera.com/media/140792/Incanthera-Investor-Presentation-May-2024.pdf